About this trial
Our aim will be to investigate the efficacy of dexmedetomidine as an adjuvant to bupivacaine in ultrasound guided pericapsular nerve group (PENG) block for postoperative analgesia in hip replacement surgeries.
* Our primary outcome of the study: total amount of postoperative morphine consumption in the first 24h postoperative. * Our secondary outcome of the study: postoperative analgesia assessed by pain score (by Visual Analog Scale)
Eligibility criteria
Qualifiers
Patients aged from 18 years to 90 years
Gender : both males and females
BMI less than 35 kg/m2
Patients with American society of anesthesiologists (ASA) classification class I , II or III
Disqualifiers
Patient declining to give written informed consent
Patient with infection at the site of injection
Patient with coagulopathy
Patients with known allergy to used medications.
Trial design
Treatments tested in this trial
- Ultrasound guided Pericapsular Nerve Group Block
- Isobaric Bupivacaine 0. 25%
- 20 ml isobaric bupivacaine 0.25% and 1.5μg/kg dexmedetomidine
- the ultrasound machine with curvilinear transducer (high -frequency probe, 2.5Mhz to 7.5Mhz)
- a standard echogenic 20-22 gauge 100mm needle